FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

732258009: Ribociclib succinate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3465010013 Ribociclib succinate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3465011012 Ribociclib succinate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ribociclib succinate Is a Ribociclib false Inferred relationship Existential restriction modifier
Ribociclib succinate Has disposition Protein kinase inhibitor true Inferred relationship Existential restriction modifier
Ribociclib succinate Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Ribociclib succinate Is a Purine false Inferred relationship Existential restriction modifier
Ribociclib succinate Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Ribociclib succinate Is a Substance with protein kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Ribociclib succinate Is modification of Ribociclib true Inferred relationship Existential restriction modifier
Ribociclib succinate Is a Purine and/or purine derivative true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ribociclib (as ribociclib succinate) 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier 1
Kisqali 200mg tablets (Originalis B.V.) 63 tablet Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Originalis B.V.) Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Ribociclib 200mg tablets Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Ribociclib 200mg tablets 63 tablet Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Ribociclib 200mg tablets 42 tablet Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Ribociclib 200mg tablets 21 tablet Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 42 tablet 3 x 14 tablets Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ribociclib succinate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start